Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Submandibular Gland Neoplasms 1Parotid Neoplasms 1Multiple Pulmonary Nodules 1Breast Neoplasms 1

Interventions

pembrolizumab 1gadobutrol 1Standard of Care 1Radiotherapy 1Radiation 1Quality of Life 1Proton Therapy 1Practice Guidelines as Topic 1Physical Examination 1Patient Reported Outcome Measures 1Multiparametric Magnetic Resonance Imaging 1Molecular Diagnostic Techniques 1Magnetic Resonance Spectroscopy 1Magnetic Resonance Imaging 1Lymph Node Excision 1Limonene 1Immunotherapy 1Erlotinib Hydrochloride 1Drug Therapy 1Docetaxel 1Citric Acid 1Cisplatin 1Biological Therapy 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Parotid Neoplasms × Limonene × Clear all
NCT04296266 2020-03-05

Human Salivary Gland Disposition of Alda-341 in Patients Undergoing Salivary Gland Surgery

Stanford University

Phase EARLY_PHASE1 Completed
10 enrolled

Parotid Neoplasms, Submandibular Gland Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡